CN109954113A

CN109954113A - Anti-tumor healthcare tea and preparation method thereof

Info

Publication number: CN109954113A
Application number: CN201711426650.2A
Authority: CN
Inventors: 由玺印
Original assignee: Individual
Current assignee: Individual
Priority date: 2017-12-26
Filing date: 2017-12-26
Publication date: 2019-07-02

Abstract

Title of the present invention is anti-tumor healthcare tea, it is characterized in that be made of following components in parts by weight: 300~500g of Radix Astragali, 300~500g of rhizoma atractylodis macrocephalae, 300~500g of trigone, 300~500g of rhizoma corydalis, 300~500g of radix bupleuri, 300~500g of Radix Curcumae, 300~500g of curcuma zedoary, 300~500g of Radix Salviae Miltiorrhizae, 300~500g of turtle shell, 300~500g of oriental wormwood, 300~500g of endothelium corneum gigeriae galli, 300~500g of Hedyotidis Diffusae, 300~500g of Sculellaria barbata, 300~500g of pheretima, 300~500g of west safflower, 300~500g of Radix Angelicae Sinensis, 300~500g of Rhizoma Chuanxiong, 300~500g of realgar, 300~500g of tealeaves.The present invention is formed according to group the characteristics of motherland's tcm theory, is formed using nourishing qi and blood, activating microcirculation and removing stasis medicinal, the herbal medicinal material removed obstruction in channels to relieve pain.Prescription raw material of the invention, is mixed to grind on the basis of not destroying original effective ingredient of herbal medicinal material capsule, granule, oral solution, pill, infusion is made.

Description

Anti-tumor healthcare tea and preparation method thereof

Technical field

Title of the present invention is anti-tumor healthcare tea, is used for daily health caring, is mainly suitable for inhibiting cancer cell abnormality proliferation, promote Tumor shrank prevents and controls the recurrence of cancer with transfer and with tumor existence purpose etc. to realize elimination tumour.

Background technique

Tumour is to seriously threaten a kind of disease of human life, more although existing treatment means achieve certain curative effect Number tumor patient life span is limited, lacks the drug that can effectively cure, needs to develop new drug and dosage form to meet It needs.Due to oncobiology progress of research, some new mechanism of action, action target spot anti-tumor drug continue to bring out, Show conventional cell poison class Drug safety different from the past and validity feature；The drug therapy of tumor disease also from For past simple pursuit tumor regression to extending the life cycle of patient, improving life quality transformation, these changes make anti-tumor drug Also there is larger change in evaluation of clinical curative effect endpoint.Therefore, traditional anti-tumor drug development mode become discomfort Preferably, need more to explore the clinical research strategy that can accelerate and promote development process.Present invention research main purpose is to investigate After drug changes dosage form, if there is antitumor action, understand the Antitumor test of drug, while drug should be carried out in more detail The observation of adverse reaction, other than common adverse reactions, it should also be noted that the rare toxicity of observation drug, drug accumulative and Repeated dose toxicity, and propose the method prevented and handle toxicity.The invention of anti-tumor healthcare tea is designed to provide: Yi Zhongjian It imitates, expense is low, for the electuary of daily health caring.95 anti-tumor healthcare tea instructions of taking of the invention are as follows: 2g is used every time, with opening Water brews, and the present invention is that more tumor patients is allowed to receive to understand Chinese traditional treatment, helps them to mitigate tumour disease pain, improves life Quality, or even extend the tea product of life cycle.

Summary of the invention

Title of the present invention is 95 anti-tumor healthcare tea, is made of following components in parts by weight: Radix Astragali 300~ 500g, 300~500g of rhizoma atractylodis macrocephalae, 300~500g of trigone, 300~500g of rhizoma corydalis, 300~500g of radix bupleuri, Radix Curcumae 300~ 500g, 300~500g of curcuma zedoary, 300~500g of Radix Salviae Miltiorrhizae, 300~500g of turtle shell, 300~500g of oriental wormwood, 300~500g of endothelium corneum gigeriae galli, 300~500g of Hedyotidis Diffusae, 300~500g of Sculellaria barbata, 300~500g of pheretima, 300~500g of west safflower, Radix Angelicae Sinensis 300~ 500g, 300~500g of Rhizoma Chuanxiong, 300~500g of realgar, 300~500g of tealeaves.The present invention is the spy according to motherland's tcm theory Point group forms, and is formed using nourishing qi and blood, activating microcirculation and removing stasis medicinal, the herbal medicinal material removed obstruction in channels to relieve pain.Prescription raw material of the invention is not being broken It is mixed to grind on the basis of original effective ingredient of bad book on Chinese herbal medicine medicinal material and capsule, granule, oral solution, pill, bubble is made Agent.

Claims

1. title of the present invention is anti-tumor healthcare tea, it is characterised in that be made of following components in parts by weight: Radix Astragali 300~ 500g, 300~500g of rhizoma atractylodis macrocephalae, 300~500g of trigone, 300~500g of rhizoma corydalis, 300~500g of radix bupleuri, Radix Curcumae 300~ 500g, 300~500g of curcuma zedoary, 300~500g of Radix Salviae Miltiorrhizae, 300~500g of turtle shell, 300~500g of oriental wormwood, 300~500g of endothelium corneum gigeriae galli, 300~500g of Hedyotidis Diffusae, 300~500g of Sculellaria barbata, 300~500g of pheretima, 300~500g of west safflower, Radix Angelicae Sinensis 300~ 500g, 300~500g of Rhizoma Chuanxiong, 300~500g of realgar, 300~500g of tealeaves.

2. anti-tumor healthcare tea according to claim 1, the wherein weight proportion of each component are as follows: Radix Astragali 500g, rhizoma atractylodis macrocephalae 500g, trigone 500g, rhizoma corydalis 500g, radix bupleuri 500g, Radix Curcumae 500g, curcuma zedoary 500g, Radix Salviae Miltiorrhizae 500g, turtle shell 500g, oriental wormwood 500g, endothelium corneum gigeriae galli 500g, Hedyotidis Diffusae 500g, Sculellaria barbata 500g, pheretima 500g, west safflower 500g, Radix Angelicae Sinensis 500g, Rhizoma Chuanxiong 500g, realgar 500g, tealeaves 500g.

3. -2 described in any item anti-tumor healthcare tea according to claim 1, it is characterised in that the composition is capsule, particle Agent, oral solution, pill, infusion.

4. the preparation method of anti-tumor healthcare tea according to claim 3, it is characterised in that be by the crude drug of each component After drying, it is pulverized and mixed and capsule, granule, oral solution, pill, infusion is made.